Clinical Trial Update: A Study To Describe The Effect Of Impaired Hepatic Function Of The Pharmacokinetics Of Palbociclib [Phase 1]

View source ↗

Summary

A Phase 1 study describing the effect of impaired hepatic function on the pharmacokinetics of palbociclib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers
• Hepatic Insufficiency

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: Pfizer | Conditions: Healthy, Hepatic Insufficiency | Phase 1 | Status: COMPLETED | Results posted: 2018-01-24